Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Using Midazolam to Improve Postoperative Pain Relief for Colorectal Cancer Patients with Anxiety or Sleep Issues

Official title: Effects of Preoperative Oral Mmidazolam on Postoperative Pain in Sleep Disturbance or Anxiety Patients Undergoing Laparoscopic Colorectal Cancer Resection- A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Study

Run by Sixth Affiliated Hospital, Sun Yat-sen University · NCT06407518 · Data updated 2026-11-12

This study is testing if giving midazolam before surgery can help colorectal cancer patients with anxiety or sleep issues feel less pain and recover faster afterward.

More Anxiety trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment280 (estimated)
SponsorSixth Affiliated Hospital, Sun Yat-sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedJuly 24, 2024
Main results expectedOctober 2025
Study endsDecember 2025
Registry record updatedApril 6, 2025
Trial IDNCT06407518 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Chinese-speaking adults aged 18-60 with a BMI of 18-30 who are scheduled for non-emergency laparoscopic colorectal cancer surgery and exhibit sleep disturbances or anxiety.

Probably not a fit

Patients with contraindications for midazolam, severe depressive symptoms, or high risk of obstructive sleep apnea may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of preoperative oral midazolam on postoperative pain relief in patients with colorectal cancer who experience sleep disturbances or anxiety. A total of 280 participants will be randomly assigned to receive either midazolam or a placebo before undergoing laparoscopic colorectal cancer surgery. The study aims to evaluate whether midazolam can enhance sleep quality, reduce postoperative pain, and expedite recovery. Additionally, it will explore the relationship between midazolam administration and stress reduction in these patients.

Why it matters

Potential benefit: If successful, this approach could significantly improve postoperative pain management and recovery for colorectal cancer patients suffering from anxiety or sleep disturbances.

How similar studies have gone: Previous studies have indicated potential benefits of improving sleep quality on postoperative pain, suggesting that this approach may yield positive results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Signed of informed consent voluntarily; 2. Native Chinese speaker; 3. Age 18-60 years old, male or female; 4. BMI 18-30 kg/m2; 5. American Society of Anesthesiologists (ASA) grade 1 or 2, New York Heart Association (NYHA) gradeⅠor Ⅱ; 6. Non-emergency laparoscopic colorectal cancer resection; 7. General anesthesia with tracheal intubation; 8. Sleep disturbance (the Insomnia Severity Index,ISI≥15 ) or Anxiety (Generalized Anxiety Disorder scale-7,GAD-7≥10 ) from admission to surgery.

Exclusion Criteria:

* 1\. Contraindications for Midazolam Oral Solution (According to the Instruction for Midazolam Oral Solution); 2. High risk of Obstructive Sleep Apnea Symptoms (Total score of STOP-Bang scale ≥3 points); 3. Suspected dementia (Total score of Mini-Mental State Examination (MMSE) according to years of education: 0 year≤19 points; 1\~6 years≤22 points; above of 6 years≤26 points); 4. Severe depressive symptom within two weeks (Total score of Patient Health Questionnaire-9 (PHQ-9)≥15); 5. History of Neurological and Psychiatric diseases (According to the electronic medical record system); 6. History of Chronic Obstructive Pulmonary Disease (According to the electronic medical record system); 7. History of Heart Failure (According to the electronic medical record system); 8. Intestinal obstruction(The electronic medical record system records those who currently have any type of intestinal obstruction); 9. Liver and renal insufficiency; 10. Have taken opioids or drugs that act on the central nervous system within one week; 11. Take CYP3A4 isoenzyme inhibitors or inducers within one week (According to the Instruction for Midazolam Oral Solution); 12. Consume any alcoholic beverage within 24 hours; 13. Substance abusers (including alcohol, drugs or addictive substances); 14. Pregnant or lactating women.

Where it's running

  • the Sixth Affiliated Hospital, Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.